On this basis, we hypothesize that BHGZD might reverse the main pathological changes of active RA, including synovial inflammation, cartilage damage, and bone erosion, via regulating TLR4/PI3K/AKT/NFκB/NLRP3 signaling. The gene discussed is PIK3CG; the disease is rheumatoid arthritis.